In this clinical trial , 129 liver transplant recipients were randomized to be monitored in real-time for HHV-6 and HHV-7 viremia by polymerase chain reaction at regular intervals from 0 to 12 weeks after transplantation ( `` monitoring '' group ) or to undergo usual care ( `` no-monitoring '' group ) .